Scopri le migliori cliniche e prezzi di Terapia SIRT in Turchia 2026

Selective Internal Radiation Therapy (SIRT) is a targeted treatment for liver tumors that delivers radioactive Yttrium-90 (Y-90) microspheres directly via the hepatic artery. It exploits tumor biology to destroy cancer from within using localized beta radiation while preserving healthy liver tissue and surrounding organs.

• Direct delivery: Radiologists guide a catheter through the groin into the hepatic artery.
• Microsphere infusion: Millions of microscopic Y-90 beads lodge permanently in tumor-feeding vessels.
• Localized radiation: Beta radiation travels only millimeters, preventing damage to healthy distant tissue.
• Dual impact: The procedure simultaneously starves tumors of blood while providing intensive internal radiotherapy.

Bookimed Expert Insight: Turkey dominates this field globally, ranking first with 388 clinics and 7,760 requests served. Expert centers like Anadolu Medical Center maintain IASIOS certification, proving they meet the highest European standards for interventional oncology. Patients often choose Istanbul because specialized centers here offer advanced SPECT scans to prevent radiation leakage into lungs or gut.

Patient Consensus: Expect symptoms like radiation flu including fever and nausea between day 3 and 7. Most feel relieved discovering SIRT provides life-extending palliative benefits with much less systemic impact than traditional chemotherapy.

SIRT success rates for liver cancer typically range from 70% to 90% for disease control. Primary liver cancer (HCC) shows objective response rates between 50% and 78%. Clinically, SIRT serves as a bridge to transplant in 10% to 39% of previously unresectable cases.

• Disease control rate: Reaches 70% to 90% across various tumor types including metastatic cases.
• HCC response: Objective tumor shrinkage occurs in 50% to 78% of primary liver cancers.
• Neuroendocrine tumors: Exceptional response observed with disease control rates reaching 86% to 94%.
• Downstaging success: Up to 39% of patients become eligible for surgery after tumor shrinkage.

Bookimed Expert Insight: Success with SIRT in Turkey often depends on personalized dosimetry, which can double response rates from 36% to 71%. Facilities like Anadolu Medical Center maintain IASIOS certification for interventional oncology. This ensures they follow the specific European standards required for precise radiation mapping and bead distribution.

Patient Consensus: Many patients find SIRT serves as an effective bridge to liver transplantation. They emphasize that tracking tumor markers monthly is essential because early progression can occur even after initial success.

Ideal candidates for SIRT therapy in Turkey include patients with intermediate-stage primary liver cancer or colorectal metastases that are unresectable. Suitable patients must demonstrate preserved liver function, typically Child-Pugh class A or B, and a good performance status. This interventional radiology procedure leverages Y-90 microspheres to target tumors directly.

• Tumor type: Primary hepatocellular carcinoma or liver-dominant metastatic disease from colorectal or neuroendocrine origins.
• Liver function: Requires Child-Pugh A or B scores to ensure the liver tolerates radiation.
• Performance status: Patients should have an ECOG score of 0 to 1 for optimal recovery.
• Disease extent: Best results occur when cancer is confined to the liver without extensive spread.

Bookimed Expert Insight: While SIRT is often a last resort, high-volume centers like Anadolu Medical Center use it as a bridge to transplant. Their affiliation with Johns Hopkins ensures protocols mirror US standards. Patients with unilateral portal vein thrombosis are still candidates here, whereas many smaller clinics may decline these complex cases.

Patient Consensus: Patients emphasize that a full PET-CT workup in Turkey is vital before starting. Many report that younger, fitter individuals under 70 tend to recover significantly faster after the microsphere injection.

Common side effects of SIRT therapy in Turkey primarily involve post-radioembolization syndrome, characterized by temporary fatigue, mild nausea, and abdominal discomfort. Most patients experience these symptoms as the radioactive microspheres target liver tumors while sparing healthy tissue during this internal radiation process.

• Post-radioembolization syndrome: Temporary fatigue, nausea, and low-grade fever occurring shortly after treatment.
• Gastrointestinal symptoms: Mild abdominal pain or loss of appetite typically resolving within days.
• Liver function: Short-term changes in liver enzymes require monitoring through follow-up blood tests.
• Radiation precautions: Strict protocols advise avoiding close contact with children for 7 days.

Bookimed Expert Insight: While many focus on the procedure day, the recovery gap is where quality matters. Top-tier Istanbul centers like Anadolu Medical Center or Medipol Mega incorporate baseline liver-blood testing into their standard SIRT protocols. This data-driven approach allows radiologists to calibrate isotope dosages precisely, significantly reducing the intensity of post-procedure fatigue compared to clinics without integrated oncology-radiology departments.

Patient Consensus: Many patients emphasize planning for 1–4 weeks of extreme fatigue. Staying hydrated and having anti-nausea medication ready are the most frequent practical recommendations shared by those treated.

SIRT therapy in Turkey typically requires 30 to 120 minutes for the actual procedure, though patients remain at the clinic all day for preparation and monitoring. Immediate recovery involves manageable fatigue and nausea for 1 to 2 weeks, with full stamina returning within 8 to 12 weeks.

• Procedure duration: Actual catheterization takes 30 to 120 minutes within a full-day clinical appointment.
• Hospital stay: Most patients undergo this as an outpatient procedure with several hours of observation.
• Immediate recovery: Expect 1 to 2 weeks of fatigue and mild nausea as primary symptoms.
• Activity restrictions: Patients should avoid heavy lifting or strenuous exercise for 1 to 2 weeks.
• Long-term timeline: Energy levels gradually improve by week 6, with full recovery by month 3.

Bookimed Expert Insight: Anadolu Medical Center and Memorial Şişli lead in SIRT volume, leveraging JCI accreditation and international affiliations like Johns Hopkins. Data shows these centers prioritize a two-stage process: a detailed simulation week followed by the actual radiation delivery. This staged approach is why patients should plan for a 7 to 10-day stay in Istanbul to ensure precise dose mapping and safety.

Patient Consensus: Patients often report persistent fatigue during the first month and emphasize the need for pre-planned rest. Many noted that tumor response is not instant, as the radiation works gradually over several months after the initial procedure.